Ceretec is a radiopharmaceutical agent used in nuclear medicine imaging to evaluate cerebral blood flow and detect areas of altered brain function. It is commonly used in the diagnosis of stroke, brain tumors, and other neurological conditions.
Ceretec works by binding to red blood cells and emitting gamma radiation, which can be detected by a gamma camera during imaging studies. This allows healthcare providers to visualize blood flow in the brain and identify areas of decreased or increased perfusion.
Before undergoing a Ceretec scan, patients should inform their healthcare provider about any allergies, medical conditions, or medications they are taking. Pregnant or breastfeeding women should also notify their healthcare provider, as Ceretec may pose risks to the fetus or infant.
During the imaging procedure, patients will receive an injection of Ceretec intravenously and then undergo a series of scans to capture images of the brain. The procedure is generally well-tolerated, with minimal side effects reported.
It is important for patients to follow any pre-imaging instructions provided by their healthcare provider, such as fasting or avoiding certain medications. After the scan, patients can resume their normal activities without any restrictions.
Overall, Ceretec is a valuable tool in the diagnosis and management of neurological conditions. It provides healthcare providers with important information about cerebral blood flow and brain function, helping to guide treatment decisions and improve patient outcomes. If you have any questions or concerns about Ceretec or nuclear medicine imaging, please consult with your healthcare provider.
EN 
ES 
FR 
PT 
ZH